Lista de obras - Walter Fiers - Dominio Público Uruguay

A "universal" human influenza A vaccine

artículo científico publicado en 2004

A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody

artículo científico publicado en 2015

A fairly conserved epitope on the hemagglutinin of influenza A (H3N2) virus with variable accessibility to neutralizing antibody

artículo científico publicado en 1995

A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus ⬇️

artículo científico publicado el 8 de abril de 2011

A universal influenza A vaccine based on the extracellular domain of the M2 protein

artículo científico publicado en 1999

An antibody which binds to the membrane-proximal end of influenza virus haemagglutinin (H3 subtype) inhibits the low-pH-induced conformational change and cell-cell fusion but does not neutralize virus ⬇️

artículo científico publicado el 1 de julio de 1998

An influenza A vaccine based on tetrameric ectodomain of matrix protein 2.

artículo científico publicado en 2008

Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective ⬇️

artículo científico publicado el 21 de octubre de 2010

Bacteriophage MS2 RNA: A correlation between the stability of the codon: Anticodon interaction and the choice of code words ⬇️

artículo científico publicado el 29 de diciembre de 1978

Bacteriophage MS2 RNA: Nucleotide Sequence of the End of the A Protein Gene and the Intercistronic Region ⬇️

artículo científico publicado el 24 de enero de 1973

Bioavailability of recombinant tumor necrosis factor determines its lethality in mice

artículo científico publicado en 2002

Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection

artículo científico publicado en 2017

CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.

artículo científico publicado en 2008

Characterization of the interaction between murine tumour necrosis factor and monoclonal antibodies

artículo científico publicado en 2002

Controlling influenza by cytotoxic T-cells: calling for help from destroyers

artículo científico publicado en 2010

Crystal Structure of the Conserved Amino Terminus of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus Gripped by an Antibody

artículo científico publicado en 2015

Cytokine research in Belgium ⬇️

artículo científico publicado el 1 de octubre de 2011

Differential activation of phospholipases during necrosis or apoptosis: A comparative study using tumor necrosis factor and anti-Fas antibodies

scholarly article by Dirk De Valck published in December 1998

Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity ⬇️

artículo científico publicado el 29 de agosto de 1995

Evaluation of recombinant A/Victoria/3/75 (H3N2) influenza neuraminidase mutants as potential broad-spectrum subunit vaccines against influenza A.

artículo científico publicado en 1998

Functional Comparison of Mx1 from Two Different Mouse Species Reveals the Involvement of Loop L4 in the Antiviral Activity against Influenza A Viruses

artículo científico publicado en 2015

Generation and Biological Characterization of Membrane-bound, Uncleavable Murine Tumor Necrosis Factor ⬇️

artículo científico publicado el 4 de agosto de 1995

Identification of caspases that cleave presenilin-1 and presenilin-2

artículo científico publicado en 1999

Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2e.

artículo científico publicado en 2013

Improved design and intranasal delivery of an M2e-based human influenza A vaccine

artículo científico publicado en 2006

Improved periplasmic production of biologically active murine interleukin-2 in Escherichia coli through a single amino acid change at the cleavage site

artículo científico publicado en 2006

In vitro conversion of the carbohydrate moiety of fungal glycoproteins to mammalian-type oligosaccharides--evidence for N-acetylglucosaminyltransferase-I-accepting glycans from Trichoderma reesei

artículo científico publicado en 1997

Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly

artículo científico publicado en 2012

Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies

artículo científico publicado en 2016

M2-based influenza vaccines: recent advances and clinical potential

artículo científico publicado en 2016

M2e-Based Universal Influenza A Vaccines

artículo científico publicado en 2015

M2e-based universal influenza A vaccine

artículo científico publicado en 2009

M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.

artículo científico publicado en 2013

M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection.

artículo científico publicado en 2017

Macrophages induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses ⬇️

artículo científico publicado el 1 de junio de 1998

Molecular and immunological characterization of soluble aggregated A/Victoria/3/75 (H3N2) influenza haemagglutinin expressed in insect cells

artículo científico publicado en 1996

Multiple signal transduction pathways regulate TNF-induced actin reorganization in macrophages: inhibition of Cdc42-mediated filopodium formation by TNF

scientific article published on 01 January 1999

Natural and long-lasting cellular immune responses against influenza in the M2e-immune host

artículo científico publicado en 2012

Oral delivery of Escherichia coli persistently infected with M2e-displaying bacteriophages partially protects against influenza A virus

artículo científico publicado en 2017

Pandemic preparedness: toward a universal influenza vaccine

artículo científico publicado en 2009

Production and purification of recombinant human interleukin-6 secreted by the yeast Saccharomyces cerevisiae

artículo científico publicado en 1991

Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages

artículo científico publicado en 2015

Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein

artículo científico publicado en 2014

Protection of Mice Against a Lethal Influenza Challenge by Immunization with Yeast‐Derived Recombinant Influenza Neuraminidase ⬇️

artículo científico publicado el 1 de julio de 1997

Protection of mice against a lethal influenza virus challenge after immunization with yeast-derived secreted influenza virus hemagglutinin

artículo científico publicado en 1999

Quiescence-inducing and antiapoptotic activities of IL-15 enhance secondary CD4+ T cell responsiveness to antigen ⬇️

artículo científico publicado el 1 de septiembre de 1998

Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice

artículo científico publicado en 2013

Recombinant neuraminidase vaccine protects against lethal influenza

artículo científico publicado en 1996

Recombinant secreted haemagglutinin protects mice against a lethal challenge of influenza virus

artículo científico publicado en 1993

Simian virus 40 mutants carrying extensive deletions in the 72-base-pair repeat region ⬇️

artículo científico publicado el 1 de julio de 1983

Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge

artículo científico publicado en 2014

Soluble recombinant influenza vaccines

artículo científico publicado en 2001

Structural characterization of N-linked oligosaccharides from cellobiohydrolase I secreted by the filamentous fungus Trichoderma reesei RUTC 30.

artículo científico publicado en 1997

Structure of the extracellular domain of matrix protein 2 of influenza A virus in complex with a protective monoclonal antibody

artículo científico publicado en 2015

The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region

artículo científico publicado en 1998

The oxidative metabolism of glutamine. A modulator of reactive oxygen intermediate-mediated cytotoxicity of tumor necrosis factor in L929 fibrosarcoma cells

artículo científico publicado en 1996

The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection

artículo científico publicado en 2005

Tumor Necrosis Factor and Lymphotoxin

Tumor necrosis factor-alpha augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (Doxil) correlates with altered Doxil pharmacokinetics

artículo científico publicado en 2004

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.

artículo científico publicado en 2009

Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies

artículo científico publicado en 2008

Universal influenza A vaccine: optimization of M2-based constructs

artículo científico publicado en 2005

Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.

artículo científico publicado en 2010

pH-dependent aggregation and secretion of soluble monomeric influenza hemagglutinin ⬇️

artículo científico publicado el 1 de enero de 1998

Lista de obras de Walter Fiers

A "universal" human influenza A vaccine

A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody

A fairly conserved epitope on the hemagglutinin of influenza A (H3N2) virus with variable accessibility to neutralizing antibody

A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus ⬇️

A universal influenza A vaccine based on the extracellular domain of the M2 protein

An antibody which binds to the membrane-proximal end of influenza virus haemagglutinin (H3 subtype) inhibits the low-pH-induced conformational change and cell-cell fusion but does not neutralize virus ⬇️

An influenza A vaccine based on tetrameric ectodomain of matrix protein 2.

Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective ⬇️

Bacteriophage MS2 RNA: A correlation between the stability of the codon: Anticodon interaction and the choice of code words ⬇️

Bacteriophage MS2 RNA: Nucleotide Sequence of the End of the A Protein Gene and the Intercistronic Region ⬇️

Bioavailability of recombinant tumor necrosis factor determines its lethality in mice

Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection

CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.

Characterization of the interaction between murine tumour necrosis factor and monoclonal antibodies

Controlling influenza by cytotoxic T-cells: calling for help from destroyers

Crystal Structure of the Conserved Amino Terminus of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus Gripped by an Antibody

Cytokine research in Belgium ⬇️

Differential activation of phospholipases during necrosis or apoptosis: A comparative study using tumor necrosis factor and anti-Fas antibodies

Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity ⬇️

Evaluation of recombinant A/Victoria/3/75 (H3N2) influenza neuraminidase mutants as potential broad-spectrum subunit vaccines against influenza A.

Functional Comparison of Mx1 from Two Different Mouse Species Reveals the Involvement of Loop L4 in the Antiviral Activity against Influenza A Viruses

Generation and Biological Characterization of Membrane-bound, Uncleavable Murine Tumor Necrosis Factor ⬇️

Identification of caspases that cleave presenilin-1 and presenilin-2

Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2e.

Improved design and intranasal delivery of an M2e-based human influenza A vaccine

Improved periplasmic production of biologically active murine interleukin-2 in Escherichia coli through a single amino acid change at the cleavage site

In vitro conversion of the carbohydrate moiety of fungal glycoproteins to mammalian-type oligosaccharides--evidence for N-acetylglucosaminyltransferase-I-accepting glycans from Trichoderma reesei

Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly

Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies

M2-based influenza vaccines: recent advances and clinical potential

M2e-Based Universal Influenza A Vaccines

M2e-based universal influenza A vaccine

M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.

M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection.

Macrophages induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses ⬇️

Molecular and immunological characterization of soluble aggregated A/Victoria/3/75 (H3N2) influenza haemagglutinin expressed in insect cells

Multiple signal transduction pathways regulate TNF-induced actin reorganization in macrophages: inhibition of Cdc42-mediated filopodium formation by TNF

Natural and long-lasting cellular immune responses against influenza in the M2e-immune host

Oral delivery of Escherichia coli persistently infected with M2e-displaying bacteriophages partially protects against influenza A virus

Pandemic preparedness: toward a universal influenza vaccine

Production and purification of recombinant human interleukin-6 secreted by the yeast Saccharomyces cerevisiae

Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages

Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein

Protection of Mice Against a Lethal Influenza Challenge by Immunization with Yeast‐Derived Recombinant Influenza Neuraminidase ⬇️

Protection of mice against a lethal influenza virus challenge after immunization with yeast-derived secreted influenza virus hemagglutinin

Quiescence-inducing and antiapoptotic activities of IL-15 enhance secondary CD4+ T cell responsiveness to antigen ⬇️

Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice

Recombinant neuraminidase vaccine protects against lethal influenza

Recombinant secreted haemagglutinin protects mice against a lethal challenge of influenza virus

Simian virus 40 mutants carrying extensive deletions in the 72-base-pair repeat region ⬇️

Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge

Soluble recombinant influenza vaccines

Structural characterization of N-linked oligosaccharides from cellobiohydrolase I secreted by the filamentous fungus Trichoderma reesei RUTC 30.

Structure of the extracellular domain of matrix protein 2 of influenza A virus in complex with a protective monoclonal antibody

The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region

The oxidative metabolism of glutamine. A modulator of reactive oxygen intermediate-mediated cytotoxicity of tumor necrosis factor in L929 fibrosarcoma cells

The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection

Tumor Necrosis Factor and Lymphotoxin

Tumor necrosis factor-alpha augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (Doxil) correlates with altered Doxil pharmacokinetics

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.

Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies

Universal influenza A vaccine: optimization of M2-based constructs

Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.

pH-dependent aggregation and secretion of soluble monomeric influenza hemagglutinin ⬇️